Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Coursera Inc., 3 years.
Coursera Inc.
Director
Cloudflare Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cloudflare Inc. June 30, 202690.3%
-
Coursera Inc. May 20, 202595.8%
-
Cloudflare Inc. June 1, 202378.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Cloudflare Inc. | Grant or award | +842 | — | — |
| Jun 11, 2026 | Coursera Inc. | Grant or award | +34,260 | — | — |
| Mar 10, 2026 | Korro Bio Inc. | Open-market purchase | +207,100 | $11.11 | $2,300,881 |
| Feb 9, 2026 | SpyGlass Pharma Inc. | Derivative conversion | +1,619,240 | — | — |
| Feb 9, 2026 | SpyGlass Pharma Inc. | Derivative conversion | +1,370,168 | — | — |
| Feb 9, 2026 | SpyGlass Pharma Inc. | Derivative conversion | +1,370,168 | — | — |
| Feb 9, 2026 | SpyGlass Pharma Inc. | Derivative conversion | +737,962 | — | — |
| Feb 9, 2026 | SpyGlass Pharma Inc. | Open-market purchase | +937,500 | $16.00 | $15,000,000 |
| Feb 9, 2026 | SpyGlass Pharma Inc. | Derivative conversion | +954,990 | — | — |
| Feb 9, 2026 | SpyGlass Pharma Inc. | Derivative conversion | +402,273 | — | — |
| Jun 5, 2025 | Cloudflare Inc. | Grant or award | +1,172 | — | — |
| May 21, 2025 | Coursera Inc. | Grant or award | +21,765 | — | — |
| Apr 17, 2025 | Trevi Therapeutics Inc. | In-the-money exercise | +1,851,852 | $1.37 | $2,537,037 |
| Sep 16, 2024 | MBX Biosciences Inc. | Derivative conversion | +1,023,103 | — | — |
| Sep 16, 2024 | MBX Biosciences Inc. | Derivative conversion | +2,091,383 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.